Equity Overview
Price & Market Data
Price: $8.73
Daily Change: +$0.34 / 3.89%
Daily Range: $8.35 - $8.73
Market Cap: $317,832,256
Daily Volume: 45,788
Performance Metrics
1 Week: 5.95%
1 Month: 45.99%
3 Months: 26.89%
6 Months: 247.8%
1 Year: 334.3%
YTD: 39.01%
Company Details
Employees: 60
Sector: Health technology
Industry: Biotechnology
Country:
Details
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.